Sub menu

 
 

Cisplatin 100mg/100mL (1 mg/mL) solution for injection, multiple dose vial (Fresenius Kabi, USA)

Section 19A approved medicine
Cisplatin 100mg/100mL (1 mg/mL) solution for injection, multiple dose vial (Fresenius Kabi, USA)
Section 19A approval holder
Orspec Pharma Pty Ltd ABN 15 634 980 417
Phone
02 4339 4239
Approved until
Status
Current
Medicines in short supply/unavailable
CISPLATIN ACCORD cisplatin 100 mg/100 mL concentrated injection vial - ARTG 286791
CISPLATIN ACCORD cisplatin 50 mg/50 mL concentrated injection vial - ARTG 286786
Indication(s)

Cisplatin may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:

  • Metastatic non-seminomatous germ cell carcinoma
  • Advanced stage, refractory ovarian carcinoma
  • Advanced stage, refractory bladder carcinoma
Related medicines shortage notifications
https://apps.tga.gov.au/Prod/msi/Search/Details/cisplatin
Images
Picture of Cisplatin 100mg/100mL (1 mg/mL) solution for injection, multiple dose vial - carton

Help us improve the Therapeutic Goods Administration site